Cubist Systematic Strategies’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.08M | Sell |
64,577
-109,245
| -63% | -$6.9M | 0.02% | 534 |
|
|
2025
Q1 | $9.21M | Buy |
+173,822
| New | +$9.21M | 0.06% | 248 |
|
|
2023
Q4 | – | Sell |
-80,102
| Closed | -$1.84M | – | 2589 |
|
|
2023
Q3 | $1.84M | Buy |
+80,102
| New | +$1.84M | 0.01% | 810 |
|
|
2023
Q2 | – | Sell |
-278,758
| Closed | -$4.97M | – | 2910 |
|
|
2023
Q1 | $4.97M | Buy |
278,758
+262,250
| +1,589% | +$4.68M | 0.03% | 603 |
|
|
2022
Q4 | $481K | Sell |
16,508
-95,003
| -85% | -$2.77M | ﹤0.01% | 2210 |
|
|
2022
Q3 | $2.73M | Buy |
111,511
+13,420
| +14% | +$329K | 0.02% | 1328 |
|
|
2022
Q2 | $407K | Buy |
+98,091
| New | +$407K | ﹤0.01% | 2746 |
|
|
2022
Q1 | – | Sell |
-14,661
| Closed | -$146K | – | 3718 |
|
|
2021
Q4 | $146K | Buy |
+14,661
| New | +$146K | ﹤0.01% | 3115 |
|
|
2020
Q4 | – | Sell |
-9,694
| Closed | -$210K | – | 2691 |
|
|
2020
Q3 | $210K | Buy |
+9,694
| New | +$210K | ﹤0.01% | 2118 |
|
|
2020
Q1 | – | Sell |
-13,919
| Closed | -$320K | – | 2410 |
|
|
2019
Q4 | $320K | Buy |
13,919
+4,567
| +49% | +$105K | 0.01% | 1812 |
|
|
2019
Q3 | $202K | Sell |
9,352
-3,270
| -26% | -$70.6K | ﹤0.01% | 1769 |
|
|
2019
Q2 | $278K | Buy |
+12,622
| New | +$278K | 0.01% | 1860 |
|
|
2018
Q3 | – | Sell |
-8,735
| Closed | -$273K | – | 2035 |
|
|
2018
Q2 | $273K | Buy |
8,735
+7,559
| +643% | +$236K | 0.01% | 1155 |
|
|
2018
Q1 | $23K | Sell |
1,176
-1,816
| -61% | -$35.5K | ﹤0.01% | 1745 |
|
|
2017
Q4 | $87K | Buy |
+2,992
| New | +$87K | ﹤0.01% | 1704 |
|